Eli Lilly Shares Surge Past $1,000 Following Strong First Quarter Performance
Eli Lilly shares crossed the $1,000 mark after a strong first-quarter report. The company’s weight-loss drugs and pipeline strength drive growth despite rising competition.
Read More